1
|
Polillo A, Foussias G, Wong AHC, Ampofo A, Stergiopoulos V, Anderson KK, Bromley S, D'Arcey J, de Oliveira C, Duda L, Henderson J, Kidd S, Kurdyak P, Wang W, Zaheer J, Voineskos AN, Kozloff N. ED to EPI: protocol for a pragmatic randomised controlled trial of an SMS (text) messaging intervention to improve the transition from the emergency department to early psychosis intervention for young people with psychosis. BMJ Open 2020; 10:e042751. [PMID: 33334839 PMCID: PMC7747582 DOI: 10.1136/bmjopen-2020-042751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
INTRODUCTION While nearly half of all new psychotic disorders are diagnosed in the emergency department (ED), most young people who present to the ED with psychosis do not receive timely follow-up with a psychiatrist, and even fewer with evidence-based early psychosis intervention (EPI) services. We aim to test an intervention delivered using short message service (SMS), a low-cost, low-complexity, youth-friendly approach, to improve transitions from the ED to EPI services. METHODS AND ANALYSIS This is a protocol for a pragmatic randomised, single blind, controlled trial with accompanying economic and qualitative evaluations conducted at the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada. A consecutive series of 186 participants aged 16-29 referred by the ED to CAMH's EPI programme will be recruited for a trial of a two-way intervention involving reminders, psychoeducation and check-ins delivered via SMS. The primary outcome will be attendance at the first consultation appointment within 30 days of study enrolment assessed through chart reviews in the electronic health record. We will also extract routine clinical measures, including the Brief Psychiatric Rating Scale, Clinical Global Impression and Service Engagement Scale, and link with provincial health administrative data to examine system-level outcomes, including ED visits and psychiatric hospitalisations, 6 months and up to 2 years after baseline. We will perform a cost-effectiveness analysis of the primary study outcome and costs incurred, calculating an incremental cost effectiveness ratio. Web-based surveys and qualitative interviews will explore intervention user experience. Patients and families with lived experience will be engaged in all aspects of the project. ETHICS AND DISSEMINATION Research Ethics Board approval has been obtained. Findings will be reported in scientific journal articles and shared with key stakeholders including youth, family members, knowledge users and decision makers. TRIAL REGISTRATION NUMBER NCT04298450.
Collapse
Affiliation(s)
- Alexia Polillo
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
| | - George Foussias
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
| | - Albert H C Wong
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Augustina Ampofo
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Vicky Stergiopoulos
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Kelly K Anderson
- Epidemiology & Biostatistics, Western University, London, Ontario, Canada
| | - Sarah Bromley
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Jessica D'Arcey
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
| | - Claire de Oliveira
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Lillian Duda
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Joanna Henderson
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Margaret and Wallace McCain Centre for Child, Youth and Family Mental Health, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Sean Kidd
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Paul Kurdyak
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Wei Wang
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Juveria Zaheer
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Aristotle N Voineskos
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
| | - Nicole Kozloff
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Psychiatry, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
2
|
Kozloff N, Foussias G, Durbin J, Sockalingam S, Addington J, Addington D, Ampofo A, Anderson KK, Barwick M, Bromley S, Cunningham JEA, Dahrouge S, Duda L, Ford C, Gallagher S, Haltigan JD, Henderson J, Jaouich A, Miranda D, Mitchell P, Morin J, de Oliveira C, Primeau V, Serhal E, Soklaridis S, Urajnik D, Whittard K, Zaheer J, Kurdyak P, Voineskos AN. Early Psychosis Intervention-Spreading Evidence-based Treatment (EPI-SET): protocol for an effectiveness-implementation study of a structured model of care for psychosis in youth and emerging adults. BMJ Open 2020; 10:e034280. [PMID: 32499262 PMCID: PMC7282307 DOI: 10.1136/bmjopen-2019-034280] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
INTRODUCTION While early psychosis intervention (EPI) has proliferated in recent years amid evidence of its effectiveness, programmes often struggle to deliver consistent, recovery-based care. NAVIGATE is a manualised model of EPI with demonstrated effectiveness consisting of four components: individualised medication management, individual resiliency training, supported employment and education and family education. We aim to implement NAVIGATE in geographically diverse EPI programmes in Ontario, Canada, evaluating implementation and its effect on fidelity to the EPI model, as well as individual-level outcomes (patient/family member-reported and interviewer-rated), system-level outcomes (captured in provincial administrative databases) and engagement of participants with lived experience. METHODS AND ANALYSIS This is a multisite, non-randomised pragmatic hybrid effectiveness-implementation type III mixed methods study coordinated at the Centre for Addiction and Mental Health (CAMH) in Toronto. Implementation is supported by the Provincial System Support Program, a CAMH-based programme with provincial offices across Ontario, and Extension of Community Healthcare Outcomes Ontario Mental Health at CAMH and the University of Toronto. The primary outcome is fidelity to the EPI model as measured using the First Episode Psychosis Services-Fidelity Scale. Four hundred participants in the EPI programmes will be recruited and followed using both individual-level assessments and health administrative data for 2 years following NAVIGATE initiation. People with lived experience will be engaged in all aspects of the project, including through youth and family advisory committees. ETHICS AND DISSEMINATION Research ethics board approval has been obtained from CAMH and institutions overseeing the local EPI programmes. Study findings will be reported in scientific journal articles and shared with key stakeholders including youth, family members, programme staff and policymakers. TRIAL REGISTRATION NUMBER NCT03919760; Pre-results.
Collapse
Affiliation(s)
- Nicole Kozloff
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
| | - George Foussias
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
| | - Janet Durbin
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Provincial System Support Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Sanjeev Sockalingam
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Education, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Jean Addington
- Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada
| | - Donald Addington
- Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada
| | - Augustina Ampofo
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Kelly K Anderson
- Epidemiology & Biostatistics, Western University, London, Ontario, Canada
| | - Melanie Barwick
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada
| | - Sarah Bromley
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Jasmyn E A Cunningham
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Simone Dahrouge
- C.T. Lamont Primary Health Care Research Centre, Bruyere Research Institute, Ottawa, Ontario, Canada
- Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - Lillian Duda
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | | | - Sheila Gallagher
- Durham Amaze Early Psychosis Intervention Program, Lakeridge Health, Whitby, Ontario, Canada
| | - John D Haltigan
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Child and Youth Psychiatry, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Joanna Henderson
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Margaret and Wallace McCain Centre for Child, Youth and Family Mental Health, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Alexia Jaouich
- Provincial System Support Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Dielle Miranda
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | | | - Josette Morin
- Regional Early Intervention in Psychosis Service, North Bay Regional Health Centre, North Bay, Ontario, Canada
| | - Claire de Oliveira
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Valerie Primeau
- Regional Early Intervention in Psychosis Service, North Bay Regional Health Centre, North Bay, Ontario, Canada
| | - Eva Serhal
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
- Telepsychiatry, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Sophie Soklaridis
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Education, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Diana Urajnik
- Human Sciences, Social and Population Health, Northern Ontario School of Medicine, Sudbury, Ontario, Canada
- Centre for Rural and Northern Health Research, Laurentian University, Sudbury, Ontario, Canada
| | - Krista Whittard
- Early Psychosis Intervention, Niagara Region Public Health, Thorold, Ontario, Canada
| | - Juveria Zaheer
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Paul Kurdyak
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Aristotle N Voineskos
- Slaight Family Centre for Youth in Transition, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
3
|
Duda L, Okhotnikova O, Sharikadze O, Zubchenko S. COMPARATIVE ANALYSIS OF PREVALENCE OF THE MOST COMMON ALERGY DISEASES IN CHILDREN OF THE KYIV REGION (UKRAINE). Georgian Med News 2019:53-58. [PMID: 31418731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Allergic diseases (AD) have been one of the most urgent problems on nowadays worldwide. In some countries with a high AD prevalence according to ISAAC Phase One, compared to ISAAC Phase Three, especially in English-speaking countries, there is a tendency to reduction of respiratory symptoms prevalence, while in other countries, on the contrary, it continues to grow. The aim of the study is to conduct a comparative analysis of the prevalence of asthma, rhinitis and eczema in the Kyiv region of Ukraine in the dynamics for the period 2017-2018 and 1998-1999, to understand current epidemiological trends. 3186 children of different age groups, living in different regions of the Kyiv region, have been surveyed. For comparative analysis, data from asthma, rhinitis and eczema and two age groups of 6-7 years (n=1647) and 13-14 years old (n=1539) were used as required by the design of ISAAC. The epidemiological study of the prevalence of AD symptoms among children in the Kyiv region in dynamics of the 19-year period showed that there was a slight decrease in the prevalence of asthma in both age groups, although their level remains rather high. But the rate of severe asthma, especially among adolescents, has risen. Thus, the prevalence of asthma symptoms among children aged 6-7 years decreased from 16.8% to 15.4% (-0.07% per year), and among adolescents from 15.2% to 11.2% (-0, 2% per year). The prevalence of rhinitis and eczema symptoms among children in the Kyiv region continues to grow in both age groups over the years, which is consistent with the global world trends. The steady growth of allergic diseases prevalence requires further investigation of causative factors and possible ways of their solution for both Ukraine as a whole and for the Kyiv region in particular. Worrying problems of insufficient asthma control also flow out from the performed analysis, especially in regards the adolescent age category, which determines the future research directions.
Collapse
Affiliation(s)
- L Duda
- ¹Shupyk National Medical Academy of Postgraduate Education, Kyiv
| | - O Okhotnikova
- ¹Shupyk National Medical Academy of Postgraduate Education, Kyiv
| | - O Sharikadze
- ¹Shupyk National Medical Academy of Postgraduate Education, Kyiv; ²Danylo Halytsky Lviv National Medical University, Ukraine
| | - S Zubchenko
- ²Danylo Halytsky Lviv National Medical University, Ukraine
| |
Collapse
|
4
|
Fedele S, Delvecchio A, De Giorgi C, Duda L, Guglielmi A, Martines G. Small bowel adenocarcinoma in a patient with a 5-year history of untreated Crohn's disease: a case report. G Chir 2018; 39:383-387. [PMID: 30563603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
AIM Complication of Crohn's disease (CD) of the small intestine is small bowel adenocarcinoma (SBA). A lot of studies on Crohn's disease have estimated the increased relative risk of small bowel carcinoma compared to the general population. In clinical settings, it is difficult to detect SBA in CD, therefore most of cases are diagnosed after surgery for strictures without suspicion of malignancy. CASE REPORT The present case concerns a 48-year-old man with a suspicious 5-year history of untreated chronic inflammatory bowel disease. The patient was admitted to our unit with persistent abdominal pain, 20 kg weight loss and intestinal obstruction, confirmed at CT scans. It was performed an emergency laparotomy, terminal ileus was resected and intestinal continuity was restored. Histological examination revealed a poorly differentiated adenocarcinoma. DISCUSSION The risk factors of SBA include long-standing and extensive Crohn's disease, young age, male sex, smoke, early onset, complications such as strictures and fistulas The most common clinical presentation of small bowel carcinoma in Crohn's disease is intestinal obstruction accompanied by wheight loss. The diagnosis is very difficult because imaging techniques may not be able to differentiate areas of small bowel carcinomas from benign fibrotic or acute inflammatory strictures. CONCLUSION Small bowel adenocarcinoma is a rare disease but this evenience must be considered in patients with strictures for Crohn's disease. Preoperative diagnosis is still highly challenging despite significant radiological and endoscopic progress.
Collapse
|
5
|
Abstract
PURPOSE OF REVIEW Tourette syndrome (TS) is a neuropsychiatric condition defined by both motor and phonic tics over a period of at least 1 year with the onset before 18 years of age. The purpose of this article is to review the use of complementary alternative medicine (CAM) in children and adults with Tourette syndrome with emphasis on recent research. RECENT FINDINGS Most patients do not tell their physician about the use of CAM unless if specifically asked. Of the studies reviewed, description of the treatment and the frequency of use were most often reported. Few studies examine the role or effectiveness of CAM in the treatment of TS specifically. SUMMARY Practitioners should be aware of current research regarding various CAM modalities used for TS patients, including efficacy, potential adverse effects, and interactions with medications. Robust data about the use of CAM, efficacy, and potential side effects is lacking and requires further research to clarify optimal use.
Collapse
Affiliation(s)
- Ashutosh Kumar
- Division of Pediatric Neurology, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033 USA
| | - L. Duda
- Division of Pediatric Neurology, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033 USA
| | - G. Mainali
- Division of Pediatric Neurology, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033 USA
| | - S. Asghar
- Division of Pediatric Neurology, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033 USA
| | - D. Byler
- Division of Pediatric Neurology, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033 USA
| |
Collapse
|
6
|
Johansson MB, Kristiansen PT, Duda L, Niklasson GA, Österlund L. Band gap states in nanocrystalline WO3 thin films studied by soft x-ray spectroscopy and optical spectrophotometry. J Phys Condens Matter 2016; 28:475802. [PMID: 27660919 DOI: 10.1088/0953-8984/28/47/475802] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Nanocrystalline tungsten trioxide (WO3) thin films prepared by DC magnetron sputtering have been studied using soft x-ray spectroscopy and optical spectrophotometry. Resonant inelastic x-ray scattering (RIXS) measurements reveal band gap states in sub-stoichiometric γ-WO3-x with x = 0.001-0.005. The energy positions of these states are in good agreement with recently reported density functional calculations. The results were compared with optical absorption measurements in the near infrared spectral region. An optical absorption peak at 0.74 eV is assigned to intervalence transfer of polarons between W sites. A less prominent peak at energies between 0.96 and 1.16 eV is assigned to electron excitation of oxygen vacancies. The latter results are supported by RIXS measurements, where an energy loss in this energy range was observed, and this suggests that electron transfer processes involving transitions from oxygen vacancy states can be observed in RIXS. Our results have implications for the interpretation of optical properties of WO3, and the optical transitions close to the band gap, which are important in photocatalytic and photoelectrochemical applications.
Collapse
Affiliation(s)
- M B Johansson
- Department of Engineering Sciences, Division of Solid State Physics, The Ångström Laboratory, Uppsala University, PO Box 534, SE-75121 Uppsala, Sweden
| | | | | | | | | |
Collapse
|
7
|
Page R, Baneux P, Vail D, Duda L, Olson P, Anestidou L, Dybdal N, Golab G, Shelton W, Salgaller M, Hardy C. Conduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations. J Vet Intern Med 2016; 30:527-35. [PMID: 26950524 PMCID: PMC4913608 DOI: 10.1111/jvim.13916] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2015] [Revised: 12/07/2015] [Accepted: 02/02/2016] [Indexed: 12/24/2022] Open
Abstract
Development of effective and safe treatments for companion animals with cancer requires the collaboration of numerous animal health professionals and the full engagement of animal owners. Establishing ‘Best Practice Recommendations’ for clinical trials in veterinary oncology represents an important step toward meeting the goal of rigorous clinical trial design and conduct that is required to establish valid evidence. Likewise, optimizing patient welfare and owner education and advocacy is crucial to meet the unique ethical obligations to both owners and animals enrolled in these clinical trials and to ensure trust in the team conducting the research. To date, ‘Best Practice Recommendations’ for clinical trial conduct have not been reported for veterinary oncology. This document summarizes the consensus of a workshop held in November, 2014 to identify relevant ethical principles and to ensure responsible conduct of clinical research in companion animals with cancer. It is intended as a working document that will be updated as advances in science and ethical considerations require. To the extent possible, existing guidelines for the conduct and oversight of clinical trials in humans have been adapted for veterinary trials to avoid duplicative effort and to facilitate integration of clinical trials such that translational research with benefits for both companion animals and humans are encouraged.
Collapse
Affiliation(s)
- R Page
- Flint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO
| | | | - D Vail
- School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI
| | - L Duda
- School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
| | - P Olson
- Olson Consulting, Animal Health and Welfare, Fort Collins, CO
| | - L Anestidou
- Institute for Laboratory Animal Research, National Academy of Sciences, Washington, DC
| | - N Dybdal
- Genentech, Inc., South San Francisco, CA
| | - G Golab
- American Veterinary Medical Association, Schaumburg, IL
| | - W Shelton
- Virtual Beast Consulting, San Mateo, CA
| | | | - C Hardy
- Flint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO
| |
Collapse
|
8
|
Nagata K, Lamb M, Goldschmidt MH, Duda L, Walton RM. The usefulness of immunohistochemistry to differentiate between nasal carcinoma and lymphoma in cats: 140 cases (1986-2000). Vet Comp Oncol 2012; 12:52-7. [PMID: 22520498 DOI: 10.1111/j.1476-5829.2012.00330.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
A retrospective evaluation of 232 feline nasal biopsies initially diagnosed as either carcinoma or lymphoma was performed by two pathologists. One or both pathologists disagreed with the original diagnosis in 15 cases (7%), 14 of which had original diagnoses of carcinoma. Out of the 232 cases, 140, including the disputed ones, were subjected to immunohistochemical staining with epithelial and lymphoid markers. Immunohistochemical staining of the 15 disputed cases showed that the original diagnoses were incorrect in 67% (10/15), unverified in 13% (2/15) and correct in 20% (3/15). Among the consensual diagnoses, immunohistochemistry revealed that 3% (4/125) of diagnoses were unverified because they did not stain for any of the markers evaluated. This report demonstrates the importance of immunohistochemistry in establishing a correct histologic diagnosis for nasal neoplasms in cats.
Collapse
Affiliation(s)
- K Nagata
- Pittsburgh Veterinary Specialty and Emergency Center, Pittsburgh, PA, 15237, USA
| | | | | | | | | |
Collapse
|
9
|
Wolever RQ, Dreusicke M, Fikkan J, Hawkins TV, Yeung S, Wakefield J, Duda L, Flowers P, Cook C, Skinner E. Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial. Diabetes Educ 2010; 36:629-39. [PMID: 20534872 DOI: 10.1177/0145721710371523] [Citation(s) in RCA: 200] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
PURPOSE The purpose of this study was to evaluate the effectiveness of integrative health (IH) coaching on psychosocial factors, behavior change, and glycemic control in patients with type 2 diabetes. METHODS Fifty-six patients with type 2 diabetes were randomized to either 6 months of IH coaching or usual care (control group). Coaching was conducted by telephone for fourteen 30-minute sessions. Patients were guided in creating an individualized vision of health, and goals were self-chosen to align with personal values. The coaching agenda, discussion topics, and goals were those of the patient, not the provider. Preintervention and postintervention assessments measured medication adherence, exercise frequency, patient engagement, psychosocial variables, and A1C. RESULTS Perceived barriers to medication adherence decreased, while patient activation, perceived social support, and benefit finding all increased in the IH coaching group compared with those in the control group. Improvements in the coaching group alone were also observed for self-reported adherence, exercise frequency, stress, and perceived health status. Coaching participants with elevated baseline A1C (>/=7%) significantly reduced their A1C. CONCLUSIONS A coaching intervention focused on patients' values and sense of purpose may provide added benefit to traditional diabetes education programs. Fundamentals of IH coaching may be applied by diabetes educators to improve patient self-efficacy, accountability, and clinical outcomes.
Collapse
Affiliation(s)
- R Q Wolever
- The Duke Integrative Medicine, Duke University Medical Center, Durham, North Carolina (Dr Wolever, Mr Dreusicke, Dr Fikkan, Ms Hawkins, Ms Yeung, Ms Wakefield, Ms Duda)
| | - M Dreusicke
- The Duke Integrative Medicine, Duke University Medical Center, Durham, North Carolina (Dr Wolever, Mr Dreusicke, Dr Fikkan, Ms Hawkins, Ms Yeung, Ms Wakefield, Ms Duda)
| | - J Fikkan
- The Duke Integrative Medicine, Duke University Medical Center, Durham, North Carolina (Dr Wolever, Mr Dreusicke, Dr Fikkan, Ms Hawkins, Ms Yeung, Ms Wakefield, Ms Duda)
| | - T V Hawkins
- The Duke Integrative Medicine, Duke University Medical Center, Durham, North Carolina (Dr Wolever, Mr Dreusicke, Dr Fikkan, Ms Hawkins, Ms Yeung, Ms Wakefield, Ms Duda)
| | - S Yeung
- The Duke Integrative Medicine, Duke University Medical Center, Durham, North Carolina (Dr Wolever, Mr Dreusicke, Dr Fikkan, Ms Hawkins, Ms Yeung, Ms Wakefield, Ms Duda)
| | - J Wakefield
- The Duke Integrative Medicine, Duke University Medical Center, Durham, North Carolina (Dr Wolever, Mr Dreusicke, Dr Fikkan, Ms Hawkins, Ms Yeung, Ms Wakefield, Ms Duda)
| | - L Duda
- The Duke Integrative Medicine, Duke University Medical Center, Durham, North Carolina (Dr Wolever, Mr Dreusicke, Dr Fikkan, Ms Hawkins, Ms Yeung, Ms Wakefield, Ms Duda)
| | - P Flowers
- Health Management Innovations, GlaxoSmithKline, Research Triangle Park, North Carolina (Ms Flowers, Dr Cook, Dr Skinner)
| | - C Cook
- Health Management Innovations, GlaxoSmithKline, Research Triangle Park, North Carolina (Ms Flowers, Dr Cook, Dr Skinner)
| | - E Skinner
- Health Management Innovations, GlaxoSmithKline, Research Triangle Park, North Carolina (Ms Flowers, Dr Cook, Dr Skinner)
| |
Collapse
|
10
|
|
11
|
Smith KE, Xue J, Duda L, Fedorov AV, Johnson PD, McCarroll W, Greenblatt M. Smith et al. reply. Phys Rev Lett 2000; 85:3986. [PMID: 11041983 DOI: 10.1103/physrevlett.85.3986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/20/2000] [Indexed: 05/23/2023]
Affiliation(s)
- KE Smith
- Department of Physics, Boston University Boston, Massachusetts 02215, USA
| | | | | | | | | | | | | |
Collapse
|
12
|
Sorenmo K, Duda L, Barber L, Cronin K, Sammarco C, Usborne A, Goldschmidt M, Shofer F. Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J Vet Intern Med 2000; 14:395-8. [PMID: 10935889 DOI: 10.1892/0891-6640(2000)014<0395:chtwsc>2.3.co;2] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Standard treatments for canine hemangiosarcoma include surgery and chemotherapy with doxorubicin, but in spite of treatment most dogs with this disease die within 6 months of diagnosis. Tumor growth and metastasis are angiogenesis dependent. Antiangiogenic drugs such as minocycline may provide therapeutic benefits in cancer patients. The purpose of this prospective study was to evaluate the efficacy of chemotherapy with doxorubicin and minocycline, an antiangiogenic agent, in dogs with hemangiosarcoma. Eighteen dogs with histologically confirmed hemangiosarcoma of any stage were treated with doxorubicin, cyclophosphamide, and minocycline. Complete staging was performed before and during the treatment period to assess remission status and response to therapy. No statistically significant difference was found in survival between the dogs treated with chemotherapy and minocycline, and historical controls consisting of dogs that received chemotherapy alone. Postmortem examination revealed widespread metastasis, suggesting that minocycline is ineffective as a single antiangiogenic agent in canine hemangiosarcoma.
Collapse
Affiliation(s)
- K Sorenmo
- Department of Clinical Studies and Pathobiology, Veterinary Hospital of the University of Pennsylvania, Philadelphia 19104, USA.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Affiliation(s)
- D. Wolany
- Physikalisches Institut, Universität Münster, Wilhelm‐Klemm‐Str. 10, D‐48149 Münster, Germany
| | - T. Fladung
- Physikalisches Institut, Universität Münster, Wilhelm‐Klemm‐Str. 10, D‐48149 Münster, Germany
| | - L. Duda
- Physikalisches Institut, Universität Münster, Wilhelm‐Klemm‐Str. 10, D‐48149 Münster, Germany
| | - J. W. Lee
- Physikalisches Institut, Universität Münster, Wilhelm‐Klemm‐Str. 10, D‐48149 Münster, Germany
| | - T. Gantenfort
- Physikalisches Institut, Universität Münster, Wilhelm‐Klemm‐Str. 10, D‐48149 Münster, Germany
| | - L. Wiedmann
- Physikalisches Institut, Universität Münster, Wilhelm‐Klemm‐Str. 10, D‐48149 Münster, Germany
| | - A. Benninghoven
- Physikalisches Institut, Universität Münster, Wilhelm‐Klemm‐Str. 10, D‐48149 Münster, Germany
| |
Collapse
|
14
|
Stagarescu CB, Duda L, Smith KE, Guo JH, Nordgren J, Singh R, Moustakas TD. Electronic structure of GaN measured using soft-x-ray emission and absorption. Phys Rev B Condens Matter 1996; 54:R17335-R17338. [PMID: 9985951 DOI: 10.1103/physrevb.54.r17335] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
15
|
Duda L, Isberg P, Mirbt S, Guo J, Hjörvarsson B, Nordgren J, Granberg P. Soft-x-ray emission study of Fe/V (001) superlattices. Phys Rev B Condens Matter 1996; 54:10393-10396. [PMID: 9984832 DOI: 10.1103/physrevb.54.10393] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
16
|
Duda L, Stöhr J, Mancini DC, Nilsson A, Wassdahl N, Nordgren J, Samant MG. Magnetic dichroism in L2,3 emission of Fe, Co, and Ni following energy-dependent excitation with circularly polarized x rays. Phys Rev B Condens Matter 1994; 50:16758-16761. [PMID: 9976070 DOI: 10.1103/physrevb.50.16758] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
17
|
Samant MG, Stöhr J, Parkin SS, Held GA, Hermsmeier BD, Herman F, Duda L, Mancini DC, Wassdahl N, Nakajima R. Induced spin polarization in Cu spacer layers in Co/Cu multilayers. Phys Rev Lett 1994; 72:1112-1115. [PMID: 10056620 DOI: 10.1103/physrevlett.72.1112] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
18
|
Wassdahl N, Nilsson A, Wiell T, Tillborg H, Duda L, Guo JH, Mårtensson N, Nordgren J, Andersen JN, Nyholm R. Soft x-ray emission studies of adsorbates. Phys Rev Lett 1992; 69:812-815. [PMID: 10047039 DOI: 10.1103/physrevlett.69.812] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
19
|
Abstract
The relationship of biting force to the duration of the masseteric silent period was studied. After introduction of a bite transducer in ten individuals, the jaw jerk reflex was elicited at specific decreases in biting force. No significant alteration in the duration of the silent period was observed.
Collapse
|
20
|
Krassusky K, Duda L. Über die Einwirkung des Ammoniaks auf die Oxyde und Chlorhydrine des Hexylens und Tetramethyläthylens. ACTA ACUST UNITED AC 1908. [DOI: 10.1002/prac.19070770108] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|